A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis
Clinical trial NCT03347110 · COMPLETED
Trial details
- NCT number
- NCT03347110
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-22
- Primary completion
- 2020-10-29
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.